Get started
Author

Kellie Chase Berg

Observed names: K. Berg, K. C. Berg, KELLIE CHASE BERG, Kellie Berg, Kellie C. Berg, Kellie Jean Chase Berg
OpenAlex ID: A5110554282
Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder
2014 · Steven Siegel, Karen Noblett, et al. · Neurourology and Urodynamics · 218
Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation
2017 · Steven Siegel, Karen Noblett, et al. · The Journal of Urology · 192
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder
2014 · Karen Noblett, Steven Siegel, et al. · Neurourology and Urodynamics · 100
Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial
2011 · Michael R. Gold, Saleem Ahmad, et al. · Heart Rhythm · 66
Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy
2009 · J. P. Singh, L. S. Rosenthal, et al. · EP Europace · 35
PDF
A Randomized Trial of the Effect of Automated Ventricular Capture on Device Longevity and Threshold Measurement in Pacemaker Patients
2008 · BRUCE A. KOPLAN, DAVID M. GILLIGAN, et al. · Pacing and Clinical Electrophysiology · 23
Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: Results from the INTRINSIC RV trial
2011 · Renee M. Sullivan, Andrea M. Russo, et al. · Heart Rhythm · 22
Clinical and Electrical Performance of Expanded Polytetrafluoroethylene‐Covered Defibrillator Leads in Comparison to Traditional Leads
2007 · BRUCE A. KOPLAN, STAN WEINER, et al. · Pacing and Clinical Electrophysiology · 13
PDF
Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients
2018 · Karen Noblett, Kellie C. Berg, et al. · Neurourology and Urodynamics · 8
Design and Rationale of the Assessment of Proper Physiologic Response with Rate Adaptive Pacing Driven by Minute Ventilation or Accelerometer (APPROPRIATE) Trial
2010 · F. Roosevelt Gilliam, Michael Giudici, et al. · Journal of Cardiovascular Translational Research · 6
Does change in device detected frequency of non-sustained or diverted episodes serve as a marker for inappropriate shock therapy? Analyses from the INTRINSIC RV and ALTITUDE-REDUCES Trials
2014 · R. M. Sullivan, M. Seth, et al. · EP Europace · 1
PDF
Mp79-17 Level of Difficulty and Trauma Associated With Removal of the Tined Lead for Sacral Neuromodulation
2018 · Steven Siegel, Jeffrey Mangel, et al. · The Journal of Urology
PDF
Long-term neurostimulator programming in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients
2018 · Steven Siegel, Jeffrey Mangel, et al. · Neurourology and Urodynamics
Mp31-16 Concomitant Overactive Bladder Medication Usage After Sacral Neuromodulation Implant
2017 · Karen Noblett, Jeffrey Mangel, et al. · The Journal of Urology
Pd26-02 the Effect of Sacral Neuromodulation on Complete Continence at 5 Years for Subjects With Urinary Incontinence
2017 · Steven Siegel, Jeffrey Mangel, et al. · The Journal of Urology
Success of a repeated tined lead trial in a refractory OAB population
2016 · Karen Noblett, Jeffrey Mangel, et al. · ics.org
Mp38-07 Effect of Baseline Characteristics and Test Stimulation Response on Sacral Neuromodulation Therapeutic Success at 12-months
2014 · Suzette E. Sutherland, Steven Siegel, et al. · The Journal of Urology
Comparison of CRT-D Device Diagnostics in HF Patients with and without Diabetes Mellitus
2007 · Andrew Kaplan, Haresh Sachanandani, et al. · Journal of Cardiac Failure
Works count: 18
Citation count: 684
H-index: 8
I10-index: 8
Year
Topic
Type